Omri Wolk

441 total citations
9 papers, 357 citations indexed

About

Omri Wolk is a scholar working on Oncology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, Omri Wolk has authored 9 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pharmacology and 3 papers in Pharmaceutical Science. Recurrent topics in Omri Wolk's work include Crystallization and Solubility Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Omri Wolk is often cited by papers focused on Crystallization and Solubility Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Omri Wolk collaborates with scholars based in Israel, United States and Spain. Omri Wolk's co-authors include Arik Dahan, Moran Zur, Gordon L. Amidon, Marival Bermejo, Riad Agbaria, Avital Beig, Gordon M. Crippen, Noa Fine‐Shamir, Peter Langguth and Toshihide Takagi and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences and Obesity Reviews.

In The Last Decade

Omri Wolk

9 papers receiving 352 citations

Peers

Omri Wolk

PS

ONCOL

PHARM

SURGE

MB

Noa Fine‐Shamir Israel

Stephanie A. Sweetana United States

Masayuki Akimoto Japan

Moran Zur Israel

Suzanne M. Caliph Australia

Rebecca L. Oberle United States

Jens Van Den Αbeele Belgium

Carl Roos Sweden

Sylvie Fernandez France

M. Wafik Gouda Saudi Arabia

Noa Fine‐Shamir Israel

Omri Wolk

196 ×1.2

PS

114 ×0.9

ONCOL

58 ×1.0

PHARM

85 ×1.6

SURGE

56 ×1.1

MB

Citations per year, relative to Omri Wolk Omri Wolk (= 1×) peers Noa Fine‐Shamir

Countries citing papers authored by Omri Wolk

Since Specialization

Citations

This map shows the geographic impact of Omri Wolk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omri Wolk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omri Wolk more than expected).

Fields of papers citing papers by Omri Wolk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omri Wolk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omri Wolk. The network helps show where Omri Wolk may publish in the future.

Co-authorship network of co-authors of Omri Wolk

This figure shows the co-authorship network connecting the top 25 collaborators of Omri Wolk. A scholar is included among the top collaborators of Omri Wolk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omri Wolk. Omri Wolk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wolk, Omri, Milica Marković, Daniel Porat, et al.. (2018). Segmental-Dependent Intestinal Drug Permeability: Development and Model Validation of In Silico Predictions Guided by In Vivo Permeability Values. Journal of Pharmaceutical Sciences. 108(1). 316–325. 15 indexed citations

2.

Azran, Carmil, Omri Wolk, Moran Zur, et al.. (2016). Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations. Obesity Reviews. 17(11). 1050–1066. 59 indexed citations

3.

Lozoya-Agulló, Isabel, Moran Zur, Omri Wolk, et al.. (2015). In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches. International Journal of Pharmaceutics. 480(1-2). 1–7. 63 indexed citations

4.

Dahan, Arik, Omri Wolk, & Riad Agbaria. (2014). Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Drug Design Development and Therapy. 8. 1563–1563. 43 indexed citations

5.

Dahan, Arik, Omri Wolk, Moran Zur, et al.. (2014). Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Codeine Phosphate. Journal of Pharmaceutical Sciences. 103(6). 1592–1600. 21 indexed citations

6.

Zur, Moran, et al.. (2014). The Low/High BCS Permeability Class Boundary: Physicochemical Comparison of Metoprolol and Labetalol. Molecular Pharmaceutics. 11(5). 1707–1714. 61 indexed citations

7.

Dahan, Arik, Omri Wolk, Sachin Mittal, et al.. (2014). Dipeptidyl Peptidase IV as a Potential Target for Selective Prodrug Activation and Chemotherapeutic Action in Cancers. Molecular Pharmaceutics. 11(12). 4385–4394. 10 indexed citations

8.

Wolk, Omri, et al.. (2013). New targeting strategies in drug therapy of inflammatory bowel disease: mechanistic approaches and opportunities. Expert Opinion on Drug Delivery. 10(9). 1275–1286. 21 indexed citations

9.

Dahan, Arik, Omri Wolk, Young Hoon Kim, et al.. (2013). Purely in Silico BCS Classification: Science Based Quality Standards for the World’s Drugs. Molecular Pharmaceutics. 10(11). 4378–4390. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact